Immunohistochemical (IHC) analysis of BM smears revealed that patients in the MM-PD group exhibited significantly higher METTL5 expression in the bone marrow compared to patients in the MM-CR group and the ND group (Fig. 1F). Here, METTL5 is linked to Miyoshi myopathy.